Justyna Pięta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Justyna Pięta has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Adrianna Tabeau
Central Clinical Hospital
10 shared publications - Agata Prokopiuk
Regional Specialist Hospital in Biała Podlaska Ul. Terebelska 57-65, 21-500 Biała Podlaska
10 shared publications - Agnieszka Pawlik
Bielanski Hospital 80 Cegłowska Street, 01-809 Warsaw
10 shared publications - Hanna Sitarek
St John Paul II Independent Public Specialist Western Hospital Daleka 11, 05-825 Grodzisk Mazowiecki, Poland
10 shared publications - Joanna Prus
Praski Hospital of Lord's Transfiguration, Aleja “Solidarności'' 67, 03-401, Warsaw, Poland
10 shared publications - Klaudia Łuczak
Central Clinical Hospital Banacha St. 1A, 02-097 Warsaw
10 shared publications
Latest Publications
- Open Access
- 9 January 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (1) , 119
Urolithiasis in Children—Clinical Picture, Pathogenesis, and Diagnostic Approach
As in adults, urolithiasis is a significant health problem in children from an early age, having a very negative impact on health and quality of life and potentially leading to kidney function impairment. The occurrence of deposits in the urinary tract in a child is almost always the result of significant predisposing factors, including metabolic defects involving the kidney or the entire body (often inherited in a Mendelian fashion), urinary tract defects, or urinary tract infections. Among metabolic disturbances, idiopathic hypercalciuria, preceded by hypocitraturia, is the most common one. Any child with nephrolithiasis requires a careful metabolic evaluation, including blood tests, urinalysis, and, in many cases, molecular diagnosis. This narrative review presents the epidemiology, pathophysiology, and diagnostic process in children with nephrolithiasis. Special emphasis is put on pathophysiological pathways leading to metabolic kidney stone disease and metabolic diagnostic steps in children with urolithiasis, as metabolic disturbances are the most common cause of recurrent urolithiasis in Europe and North America. Nephrolithiasis should be treated as a symptom of renal or systemic disorders, and in every child, the cause of these disorders should be sought to prevent recurrence.
- 9 January 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (1) , 119
Open AccessUrolithiasis in Children—Clinical Picture, Pathogenesis, and Diagnostic Approach
As in adults, urolithiasis is a significant health problem in children from an early age, having a very negative impact on health and quality of life and potentially leading to kidney function impairment. The occurrence of deposits in the urinary tract in a child is almost always the result of significant predisposing factors, including metabolic defects involving the kidney or the entire body (often inherited in a Mendelian fashion), urinary tract defects, or urinary tract infections. Among metabolic disturbances, idiopathic hypercalciuria, preceded by hypocitraturia, is the most common one. Any child with nephrolithiasis requires a careful metabolic evaluation, including blood tests, urinalysis, and, in many cases, molecular diagnosis. This narrative review presents the epidemiology, pathophysiology, and diagnostic process in children with nephrolithiasis. Special emphasis is put on pathophysiological pathways leading to metabolic kidney stone disease and metabolic diagnostic steps in children with urolithiasis, as metabolic disturbances are the most common cause of recurrent urolithiasis in Europe and North America. Nephrolithiasis should be treated as a symptom of renal or systemic disorders, and in every child, the cause of these disorders should be sought to prevent recurrence.
- Open Access
- 6 May 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 80, 59642
Stronger Together: How GLP-1 RAs and SGLT-2 Inhibitors Revolutionize Type 2 Diabetes Treatment
Introduction: Type 2 diabetes affects approximately 462 million people worldwide. The condition is associated with complex pathophysiology that leads to impaired glucose regulation and the development of both macrovascular and microvascular complications. The economic burden is significant, with high treatment costs and lost productivity due to complications and premature mortality. Current guidelines recommend using glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose cotransporter-2 (SGLT-2) inhibitors in combination for patients at high risk for cardiovascular disease or chronic kidney disease. These treatments have been shown in multiple meta-analyses to reduce the risk of major cardiovascular events, mortality, myocardial infarction, renal failure, and severe hyperglycaemia. Purpose: This review examines the impact of combining GLP-1 receptor agonists and SGLT-2 inhibitors in patients with type 2 diabetes, with a particular focus on cardiovascular risk. Materials and methods: The review analyzed PubMed articles published in the past 10 years, including clinical studies that assessed the effects of combination therapy with GLP-1 receptor agonists and SGLT-2 inhibitors in patients with type 2 diabetes. Summary: Research indicates that the combination of GLP-1 receptor agonists and SGLT-2 inhibitors leads to improved glycaemic control, better lipid management, lower blood pressure, and reduced body weight. It also improves vascular and myocardial health markers, while reducing cardiovascular risk. Although this combination therapy benefits kidney health, certain areas remain unchanged. Considering all of this, combination therapy seems to be a promising treatment, offering greater benefits than other antidiabetic therapies.
- 6 May 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 80, 59642
Open AccessStronger Together: How GLP-1 RAs and SGLT-2 Inhibitors Revolutionize Type 2 Diabetes Treatment
Introduction: Type 2 diabetes affects approximately 462 million people worldwide. The condition is associated with complex pathophysiology that leads to impaired glucose regulation and the development of both macrovascular and microvascular complications. The economic burden is significant, with high treatment costs and lost productivity due to complications and premature mortality. Current guidelines recommend using glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose cotransporter-2 (SGLT-2) inhibitors in combination for patients at high risk for cardiovascular disease or chronic kidney disease. These treatments have been shown in multiple meta-analyses to reduce the risk of major cardiovascular events, mortality, myocardial infarction, renal failure, and severe hyperglycaemia. Purpose: This review examines the impact of combining GLP-1 receptor agonists and SGLT-2 inhibitors in patients with type 2 diabetes, with a particular focus on cardiovascular risk. Materials and methods: The review analyzed PubMed articles published in the past 10 years, including clinical studies that assessed the effects of combination therapy with GLP-1 receptor agonists and SGLT-2 inhibitors in patients with type 2 diabetes. Summary: Research indicates that the combination of GLP-1 receptor agonists and SGLT-2 inhibitors leads to improved glycaemic control, better lipid management, lower blood pressure, and reduced body weight. It also improves vascular and myocardial health markers, while reducing cardiovascular risk. Although this combination therapy benefits kidney health, certain areas remain unchanged. Considering all of this, combination therapy seems to be a promising treatment, offering greater benefits than other antidiabetic therapies.
- Open Access
- 2 May 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 81, 60024
The Impact of Immune Checkpoint Inhibitors on Fertility Preservation and Pregnancy Outcomes
Immune checkpoint inhibitors have revolutionized cancer treatment by enhancing anti-tumor immune responses. However, their impact on fertility is an emerging concern, particularly among young patients, including children. This review aims to assess the effects of immune checkpoint inhibitors on reproductive health and fertility preservation strategies. Immune checkpoint inhibitors may cause endocrine-related adverse effects, such as hypophysitis, thyroid dysfunction, and adrenal insufficiency, which can disrupt gonadal function. In women, these therapies may reduce ovarian reserve, impair ovulation, and cause menstrual irregularities. In men, they may contribute to testosterone deficiency and reduced sperm production. Given that immune checkpoint inhibitors are used even in pediatric oncology, early fertility counseling and preservation strategies, such as oocyte and sperm cryopreservation, should be discussed before treatment. Additionally, recent evidence suggests that physical activity may have a protective effect on reproductive health in patients receiving these therapies by regulating hormonal balance and reducing inflammation. Immune checkpoint inhibitor therapy may contribute to pregnancy-related disorders, with reported adverse effects including miscarriage and preterm birth, however some studies document successful pregnancies in women exposed to this treatment. As immune checkpoint inhibitors continue to be widely used, further research is needed to clarify their long-term effects on reproductive health and optimize fertility preservation strategies for affected patients.
- 2 May 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 81, 60024
Open AccessThe Impact of Immune Checkpoint Inhibitors on Fertility Preservation and Pregnancy Outcomes
Immune checkpoint inhibitors have revolutionized cancer treatment by enhancing anti-tumor immune responses. However, their impact on fertility is an emerging concern, particularly among young patients, including children. This review aims to assess the effects of immune checkpoint inhibitors on reproductive health and fertility preservation strategies. Immune checkpoint inhibitors may cause endocrine-related adverse effects, such as hypophysitis, thyroid dysfunction, and adrenal insufficiency, which can disrupt gonadal function. In women, these therapies may reduce ovarian reserve, impair ovulation, and cause menstrual irregularities. In men, they may contribute to testosterone deficiency and reduced sperm production. Given that immune checkpoint inhibitors are used even in pediatric oncology, early fertility counseling and preservation strategies, such as oocyte and sperm cryopreservation, should be discussed before treatment. Additionally, recent evidence suggests that physical activity may have a protective effect on reproductive health in patients receiving these therapies by regulating hormonal balance and reducing inflammation. Immune checkpoint inhibitor therapy may contribute to pregnancy-related disorders, with reported adverse effects including miscarriage and preterm birth, however some studies document successful pregnancies in women exposed to this treatment. As immune checkpoint inhibitors continue to be widely used, further research is needed to clarify their long-term effects on reproductive health and optimize fertility preservation strategies for affected patients.
- Open Access
- 26 April 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 80, 59456
The emerging role of proactive therapy in atopic dermatitis and psoriasis
Proactive therapy represents an evolving approach in the long-term management of atopic dermatitis (AD) and psoriasis. Unlike reactive treatment, which targets active symptoms, proactive therapy involves the intermittent, low-dose application of anti-inflammatory agents to previously affected but clinically healed skin to prevent flare-ups. This strategy aims to reduce subclinical inflammation, extend remission periods, and improve patient quality of life. A growing body of evidence supports the efficacy of proactive treatment with topical corticosteroids, calcineurin inhibitors, and vitamin D analogues, demonstrating significant reductions in relapse rates and treatment costs. However, patient adherence remains a key challenge, necessitating structured follow-up and patient education initiatives. This review explores the pathophysiological basis of proactive therapy, its clinical applications, and current evidence supporting its role in AD and psoriasis management. Additionally, we discuss safety concerns, particularly regarding skin atrophy and hypothalamic-pituitary-adrenal axis suppression, and highlight emerging therapeutic options. While proactive therapy has demonstrated a favourable benefit-risk profile, further studies are needed to refine treatment protocols and expand its application to broader patient populations.
- 26 April 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 80, 59456
Open AccessThe emerging role of proactive therapy in atopic dermatitis and psoriasis
Proactive therapy represents an evolving approach in the long-term management of atopic dermatitis (AD) and psoriasis. Unlike reactive treatment, which targets active symptoms, proactive therapy involves the intermittent, low-dose application of anti-inflammatory agents to previously affected but clinically healed skin to prevent flare-ups. This strategy aims to reduce subclinical inflammation, extend remission periods, and improve patient quality of life. A growing body of evidence supports the efficacy of proactive treatment with topical corticosteroids, calcineurin inhibitors, and vitamin D analogues, demonstrating significant reductions in relapse rates and treatment costs. However, patient adherence remains a key challenge, necessitating structured follow-up and patient education initiatives. This review explores the pathophysiological basis of proactive therapy, its clinical applications, and current evidence supporting its role in AD and psoriasis management. Additionally, we discuss safety concerns, particularly regarding skin atrophy and hypothalamic-pituitary-adrenal axis suppression, and highlight emerging therapeutic options. While proactive therapy has demonstrated a favourable benefit-risk profile, further studies are needed to refine treatment protocols and expand its application to broader patient populations.
- Open Access
- 26 April 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 80, 59459
The Role of Physical Activity in Male Reproductive Health – A Systematic Review
Introduction and purpose: Nowadays infertility is an important problem, which affects even 17,5% couples during their lifetime. There are many factors playing a role in the development of infertility, among others the ones connected with lifestyle. There are many studies analysing lifestyle influence on the male reproductive health. The aim of this article is to review available literature concerning physical activity and to analyse its impact on male fertility, considering different exercise-related mechanisms, which may cause impairments. Materials and Methods: The literature review was conducted via PubMed database and the search terms were as follows: “physical activity”, “sport”, “male fertility” and “male infertility”. We included only the articles written in English and the search was limited to the following types of articles: clinical trials, meta-analyses, systematic reviews and reviews. The studies cited in the mentioned reviews were also included. State of knowledge: Physical activity affects male reproductive health on both ways – moderate exercise has a positive effect on male fertility, while an extent activity impairs it. The negative effect is caused by many mechanisms, such as impairing the functioning of hormonal axes, worsening semen parameters or injuries causing urogenital disorders. Conclusions: People, particularly men with lifestyle-induced infertility issues, should be enhanced to sport. It is important to maintain an appropriate, moderate level of physical activity though. Further research in this field is still needed, because of the importance and prevalence of the infertility question.
- 26 April 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 80, 59459
Open AccessThe Role of Physical Activity in Male Reproductive Health – A Systematic Review
Introduction and purpose: Nowadays infertility is an important problem, which affects even 17,5% couples during their lifetime. There are many factors playing a role in the development of infertility, among others the ones connected with lifestyle. There are many studies analysing lifestyle influence on the male reproductive health. The aim of this article is to review available literature concerning physical activity and to analyse its impact on male fertility, considering different exercise-related mechanisms, which may cause impairments. Materials and Methods: The literature review was conducted via PubMed database and the search terms were as follows: “physical activity”, “sport”, “male fertility” and “male infertility”. We included only the articles written in English and the search was limited to the following types of articles: clinical trials, meta-analyses, systematic reviews and reviews. The studies cited in the mentioned reviews were also included. State of knowledge: Physical activity affects male reproductive health on both ways – moderate exercise has a positive effect on male fertility, while an extent activity impairs it. The negative effect is caused by many mechanisms, such as impairing the functioning of hormonal axes, worsening semen parameters or injuries causing urogenital disorders. Conclusions: People, particularly men with lifestyle-induced infertility issues, should be enhanced to sport. It is important to maintain an appropriate, moderate level of physical activity though. Further research in this field is still needed, because of the importance and prevalence of the infertility question.
- Open Access
- 26 April 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 80, 59454
The Impact of pregnancy and birth-related risk factors on the incidence of developmental dysplasia of the hip in newborns
Introduction: Developmental dysplasia of the hip (DDH) is a multifactorial condition that, if untreated, can lead to long-term complications such as early-onset osteoarthritis and disability. Risk factors, including breech presentation, family history, female sex, firstborn status, high birth weight, and oligohydramnios, are associated with 50–60% of DDH cases. Screening approaches vary, with selective and universal ultrasound strategies in use. This review examines DDH risk factors related to birth and pregnancy, emphasizing the importance of early diagnosis and timely intervention to improve patient outcomes. Aim of study: This review explores current knowledge on risk factors for developmental dysplasia of the hip related to birth and pregnancy, highlighting their role in enhancing early diagnosis and timely intervention for affected newborns. Material and methods:A systematic review of PubMed literature (2019–2024) was conducted using the terms "DDH," "Risk factors," and either "pregnancy" or "birth," with studies manually screened for relevance and credibility, Results and conclusion: Developmental dysplasia of the hip (DDH) is the most common musculoskeletal disorder in infants, with risk factors including breech presentation, oligohydramnios, primiparity, high birth weight, and uterine scarring. Breech positioning and restricted fetal movements due to low amniotic fluid volume can impair hip joint development. Primiparity and high birth weight may also contribute to DDH by increasing mechanical pressure on the hip. This review analyzes pregnancy-related risk factors for DDH and highlights the importance of early diagnosis through selective screening to improve neonatal outcomes
- 26 April 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 80, 59454
Open AccessThe Impact of pregnancy and birth-related risk factors on the incidence of developmental dysplasia of the hip in newborns
Introduction: Developmental dysplasia of the hip (DDH) is a multifactorial condition that, if untreated, can lead to long-term complications such as early-onset osteoarthritis and disability. Risk factors, including breech presentation, family history, female sex, firstborn status, high birth weight, and oligohydramnios, are associated with 50–60% of DDH cases. Screening approaches vary, with selective and universal ultrasound strategies in use. This review examines DDH risk factors related to birth and pregnancy, emphasizing the importance of early diagnosis and timely intervention to improve patient outcomes. Aim of study: This review explores current knowledge on risk factors for developmental dysplasia of the hip related to birth and pregnancy, highlighting their role in enhancing early diagnosis and timely intervention for affected newborns. Material and methods:A systematic review of PubMed literature (2019–2024) was conducted using the terms "DDH," "Risk factors," and either "pregnancy" or "birth," with studies manually screened for relevance and credibility, Results and conclusion: Developmental dysplasia of the hip (DDH) is the most common musculoskeletal disorder in infants, with risk factors including breech presentation, oligohydramnios, primiparity, high birth weight, and uterine scarring. Breech positioning and restricted fetal movements due to low amniotic fluid volume can impair hip joint development. Primiparity and high birth weight may also contribute to DDH by increasing mechanical pressure on the hip. This review analyzes pregnancy-related risk factors for DDH and highlights the importance of early diagnosis through selective screening to improve neonatal outcomes
- Open Access
- 23 April 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 80, 59415
How Does Prenatal Exercise Affect Labor and Delivery? A Review of the Influence of Prenatal Physical Activity on the Course of Vaginal Birth
Introduction and purpose: Regular physical activity during pregnancy is associated with many maternal health benefits, including a reduced risk of complications during pregnancy. This review explores its impact on vaginal birth outcomes, focusing on labor induction, duration, pain tolerance, instrumental delivery rates, and episiotomy or laceration occurrences. Results: Studies suggest that prenatal exercise may lower the likelihood of labor induction and instrumental deliveries. Regular physical activity, including aerobic exercises, resistance training, and targeted prenatal workouts, has been associated with a higher rate of spontaneous labor onset, reducing the need for medical interventions such as oxytocin induction. Yoga and Pilates, in particular, have shown promising effects in enhancing pain tolerance during labor by improving flexibility, muscle strength, and relaxation techniques, which may help women manage contractions more effectively. While some research indicates that yoga can potentially shorten labor duration, findings remain inconclusive. Additionally, despite the numerous benefits of prenatal exercise, studies consistently report no significant impact on the rate of episiotomies or perineal lacerations. Conclusions: This review of literature shows that regular physical activity during pregnancy may reduce the need for labor induction, improve pain management, and lower the likelihood of instrumental deliveries. There is no doubt that prenatal physical activity may positively influence the course of spontaneous vaginal delivery by reducing the need for obstetric interventions.
- 23 April 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 80, 59415
Open AccessHow Does Prenatal Exercise Affect Labor and Delivery? A Review of the Influence of Prenatal Physical Activity on the Course of Vaginal Birth
Introduction and purpose: Regular physical activity during pregnancy is associated with many maternal health benefits, including a reduced risk of complications during pregnancy. This review explores its impact on vaginal birth outcomes, focusing on labor induction, duration, pain tolerance, instrumental delivery rates, and episiotomy or laceration occurrences. Results: Studies suggest that prenatal exercise may lower the likelihood of labor induction and instrumental deliveries. Regular physical activity, including aerobic exercises, resistance training, and targeted prenatal workouts, has been associated with a higher rate of spontaneous labor onset, reducing the need for medical interventions such as oxytocin induction. Yoga and Pilates, in particular, have shown promising effects in enhancing pain tolerance during labor by improving flexibility, muscle strength, and relaxation techniques, which may help women manage contractions more effectively. While some research indicates that yoga can potentially shorten labor duration, findings remain inconclusive. Additionally, despite the numerous benefits of prenatal exercise, studies consistently report no significant impact on the rate of episiotomies or perineal lacerations. Conclusions: This review of literature shows that regular physical activity during pregnancy may reduce the need for labor induction, improve pain management, and lower the likelihood of instrumental deliveries. There is no doubt that prenatal physical activity may positively influence the course of spontaneous vaginal delivery by reducing the need for obstetric interventions.
- Open Access
- 22 April 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 80, 59398
The Neuroprotective Effects of GLP-1 Analogues on Alzheimer's Disease – A Literature Review
Alzheimer’s disease (AD), often referred to as type 3 diabetes, is characterized by neuroinflammation, oxidative stress, mitochondrial dysfunction, and brain insulin resistance, leading to cognitive decline. GLP-1 receptor agonists, originally developed for type 2 diabetes, demonstrate neuroprotective properties that address these pathologies. They improve insulin sensitivity, reduce amyloid-beta deposition, tau hyperphosphorylation, and neuronal apoptosis while enhancing synaptic plasticity, autophagy, and neural stem cell proliferation. Studies highlight their potential as innovative AD therapies. However, further research is needed to confirm their efficacy and long-term safety in combating neurodegeneration.
- 22 April 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 80, 59398
Open AccessThe Neuroprotective Effects of GLP-1 Analogues on Alzheimer's Disease – A Literature Review
Alzheimer’s disease (AD), often referred to as type 3 diabetes, is characterized by neuroinflammation, oxidative stress, mitochondrial dysfunction, and brain insulin resistance, leading to cognitive decline. GLP-1 receptor agonists, originally developed for type 2 diabetes, demonstrate neuroprotective properties that address these pathologies. They improve insulin sensitivity, reduce amyloid-beta deposition, tau hyperphosphorylation, and neuronal apoptosis while enhancing synaptic plasticity, autophagy, and neural stem cell proliferation. Studies highlight their potential as innovative AD therapies. However, further research is needed to confirm their efficacy and long-term safety in combating neurodegeneration.
- Open Access
- 15 April 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 80, 59416
The Silent Risks of Sleepless Nights: Can short sleep duration be considered a significant risk factor for hypertension? - A literature review
Introduction and purpose Hypertension is one of the most common diseases worldwide affecting more than 30% of the global adult population. It can lead to serious complications. Making it a major concern for modern medicine. While traditional risk factors such as obesity, diet and lifestyle choices are well known, recent evidence suggests that short sleep duration may also play a significant role in the development of hypertension. The aim of this study is to summarise information on the impact of short sleep duration on the incidence and pathophysiology of hypertension. Methods A systematic review of scientific articles published between 2015 and 2024 was conducted using PubMed. Articles were searched using the following terms: hypertension, high blood pressure, short sleep duration, sleep deficiency . Brief Description Of The State Of Knowledge Current literature suggests that sleep deprivation influences blood pressure regulation through multiple pathways, including autonomic nervous system dysfunction, increased inflammation, oxidative stress, and metabolic disturbances. Observational studies indicate a higher incidence of hypertension among individuals sleeping less than six hours per night, with variations based on age and sex. Meta-analyses confirm the relationship, where short sleep durations correlate with increased hypertension risk. Summary Short sleep duration is a modifiable yet often overlooked risk factor for hypertension. Given the high prevalence of sleep deficiency in modern society, integrating sleep hygiene recommendations into hypertension prevention strategies may be beneficial. Further research utilizing objective sleep measurements is essential to establish causality and develop targeted interventions.
- 15 April 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 80, 59416
Open AccessThe Silent Risks of Sleepless Nights: Can short sleep duration be considered a significant risk factor for hypertension? - A literature review
Introduction and purpose Hypertension is one of the most common diseases worldwide affecting more than 30% of the global adult population. It can lead to serious complications. Making it a major concern for modern medicine. While traditional risk factors such as obesity, diet and lifestyle choices are well known, recent evidence suggests that short sleep duration may also play a significant role in the development of hypertension. The aim of this study is to summarise information on the impact of short sleep duration on the incidence and pathophysiology of hypertension. Methods A systematic review of scientific articles published between 2015 and 2024 was conducted using PubMed. Articles were searched using the following terms: hypertension, high blood pressure, short sleep duration, sleep deficiency . Brief Description Of The State Of Knowledge Current literature suggests that sleep deprivation influences blood pressure regulation through multiple pathways, including autonomic nervous system dysfunction, increased inflammation, oxidative stress, and metabolic disturbances. Observational studies indicate a higher incidence of hypertension among individuals sleeping less than six hours per night, with variations based on age and sex. Meta-analyses confirm the relationship, where short sleep durations correlate with increased hypertension risk. Summary Short sleep duration is a modifiable yet often overlooked risk factor for hypertension. Given the high prevalence of sleep deficiency in modern society, integrating sleep hygiene recommendations into hypertension prevention strategies may be beneficial. Further research utilizing objective sleep measurements is essential to establish causality and develop targeted interventions.
- Open Access
- 7 April 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 40, 59477
Pelvic floor dysfunctions in female athletes
Pelvic floor dysfunctions (PFD) consists of disorders that involve urinary incontinence (UI), anorectal dysfunction, pelvic organ prolapse (POP), sexual dysfunction and pelvic pain. While physical activity benefits overall health, high-impact and strenuous exercise may contribute to PFD due to increased intra-abdominal pressure. This study examined PFD prevalence in female athletes and their knowledge of the condition. The prevalence of UI is significantly higher in female athletes compared to the general population, with high-impact sports such as gymnastics, basketball, and volleyball demonstrating the greatest risk. Anorectal dysfunction is less studied but appears more prevalent in endurance and high-intensity athletes. POP remains underexplored, though some studies suggest sports do not worsen the symptoms. Additionally, sexual dysfunction, particularly dyspareunia, is common but poorly understood among athletes. Despite the high prevalence of PFD, knowledge among sportswomen remains limited, with misconceptions contributing to reluctance in seeking medical care. There is a pressing need for educational interventions to improve awareness of PFD in female athletes. Additionally, the implementation of pelvic floor muscle training (PFMT) has shown promise in preventing and managing UI. Future research should expand beyond UI and particularly include sexual health and anorectal dysfunction, to ensure comprehensive care for female athletes.
- 7 April 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 40, 59477
Open AccessPelvic floor dysfunctions in female athletes
Pelvic floor dysfunctions (PFD) consists of disorders that involve urinary incontinence (UI), anorectal dysfunction, pelvic organ prolapse (POP), sexual dysfunction and pelvic pain. While physical activity benefits overall health, high-impact and strenuous exercise may contribute to PFD due to increased intra-abdominal pressure. This study examined PFD prevalence in female athletes and their knowledge of the condition. The prevalence of UI is significantly higher in female athletes compared to the general population, with high-impact sports such as gymnastics, basketball, and volleyball demonstrating the greatest risk. Anorectal dysfunction is less studied but appears more prevalent in endurance and high-intensity athletes. POP remains underexplored, though some studies suggest sports do not worsen the symptoms. Additionally, sexual dysfunction, particularly dyspareunia, is common but poorly understood among athletes. Despite the high prevalence of PFD, knowledge among sportswomen remains limited, with misconceptions contributing to reluctance in seeking medical care. There is a pressing need for educational interventions to improve awareness of PFD in female athletes. Additionally, the implementation of pelvic floor muscle training (PFMT) has shown promise in preventing and managing UI. Future research should expand beyond UI and particularly include sexual health and anorectal dysfunction, to ensure comprehensive care for female athletes.